title: Responses to docetaxel plus vinorelbine in metastatic breast cancer patients failing high-dose chemotherapy.
authors.forename: R
authors.initials: R
authors.lastname: Andres
authors.forename: J I
authors.initials: JI
authors.lastname: Mayordomo
authors.forename: D
authors.initials: D
authors.lastname: Isla
authors.forename: J L
authors.initials: JL
authors.lastname: Marti
authors.forename: P
authors.initials: P
authors.lastname: Escudero
authors.forename: E
authors.initials: E
authors.lastname: Filipovich
authors.forename: A
authors.initials: A
authors.lastname: Saenz
authors.forename: I
authors.initials: I
authors.lastname: Alvarez
authors.forename: E
authors.initials: E
authors.lastname: Polo
authors.forename: A
authors.initials: A
authors.lastname: Tres
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000188:drug therapy*; D000077143:Docetaxel; D005260:Female; D006801:Humans; D017239:Paclitaxel / Q000008:administration & dosage* / Q000031:analogs & derivatives*; D043823:Taxoids; D014747:Vinblastine / Q000008:administration & dosage* / Q000031:analogs & derivatives*; D000077235:Vinorelbine
chemical_list: D043823:Taxoids; D000077143:Docetaxel; D014747:Vinblastine; D017239:Paclitaxel; D000077235:Vinorelbine